A Study of Sasanlimab, Palbociclib and Axitinib in Metastatic Renal Cell Carcinoma
Conditions
- Metastatic Renal Cell Carcinoma
- Metastatic Renal Cancer
- Renal Cell Carcinoma
- Advanced Clear Cell Renal Cell Carcinoma
- Kidney Cancer
- Translocation Renal Cell Carcinoma
Interventions
- DRUG: Sasanlimab
- DRUG: Palbociclib
- DRUG: Axitinib
Sponsor
Stephanie Berg
Collaborators